Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, PROCTER & GAMBLE Co insiders sold a net $15.0M of stock across 302 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Oct 5, 2026.
The trade is 9.3% of the 46,792 shares held after it.
4 other insiders sold within 30 days.
1,867 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO- Health Care Gama Paul sold about $698.5K of PG on Oct 23, 2026; 4 other insiders sold within 30 days and 1,867 funds added in the latest 13F quarter.
17 earlier Form 4 trades (code P or S) here by this insider (17 sales), the last on Aug 20, 2026.
The trade is 37.0% of the 11,295 shares held after it.
4 other insiders sold within 30 days.
1,867 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Human Resources Officer Purushothaman Balaji sold about $671.9K of PG on Oct 23, 2026; 4 other insiders sold within 30 days and 1,867 funds added in the latest 13F quarter.
19 earlier Form 4 trades (code P or S) here by this insider (19 sales), the last on Aug 20, 2026.
The trade is 63.2% of the 55,390 shares held after it.
4 other insiders sold within 30 days.
1,867 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman, President and CEO Jejurikar Shailesh sold about $5.7M of PG on Oct 23, 2026; 4 other insiders sold within 30 days and 1,867 funds added in the latest 13F quarter.
18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on Aug 20, 2026.
The trade is 7.7% of the 30,729 shares held after it.
4 other insiders sold within 30 days.
1,867 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer & Secy Whaley Susan Street sold about $344.3K of PG on Oct 5, 2026; 4 other insiders sold within 30 days and 1,867 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 20, 2026.
The trade is 4.4% of the 51,123 shares held after it.
4 other insiders sold within 30 days.
1,867 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO- Health Care Gama Paul sold about $323.4K of PG on Oct 5, 2026; 4 other insiders sold within 30 days and 1,867 funds added in the latest 13F quarter.
302 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
PG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Santos de Azevedo Juliana Monteiro
Filed 2026-10-26
$873.0K
Gama Paul
Filed 2026-10-22
$2.3M
Jejurikar Shailesh
Filed 2026-10-22
$5.5M
Raman Sundar G.
Filed 2026-10-22
$6.0M
Purushothaman Balaji
Filed 2026-10-22
$659.5K
PG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
iShares U.S. Consumer Staples ETF
$181.4M position · as of 2026-07-31
12.8%
Global X PureCap MSCI Consumer Staples ETF
$6.8M position · as of 2026-05-31
11.3%
JNL/Mellon Consumer Staples Sector Fund
$42.5M position · as of 2026-06-30
11.1%
Select Consumer Staples Portfolio
$126.4M position · as of 2026-05-31
10.6%
VIP Consumer Staples Portfolio
$24.4M position · as of 2026-06-30
10.5%
VANGUARD CONSUMER STAPLES INDEX FUND
$852.4M position · as of 2026-05-31
9.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
The Procter & Gamble Company Good Government Fund
Cycle 2026 · $201K spent
$197.7K
Federal Election Commission, matched by the PAC's connected organisation
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $15.0M sold by insiders over 180 days, 1,867 funds added last quarter, 6 House member(s) bought in 12 months, disclosed weeks after the trade, $29.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$87.9B
four quarters, 2025-10-01 to 2026-09-30
Revenue, TTM PG
FY Jun 2026
$87.0B
FY Jun 2025
$84.3B
FY Jun 2024
$84.0B
FY Jun 2023
$82.0B
FY Jun 2022
$80.2B
Sep 2026
$23.3B
Jun 2026
$21.2B
Mar 2026
$21.2B
Dec 2025
$22.2B
Sep 2025
$22.4B
Jun 2025
$20.9B
Mar 2025
$19.8B
Dec 2024
$21.9B
At each fiscal year end
Single quarter
Net margin, TTM
+18.2%
net income over revenue, 2025-10-01 to 2026-09-30
Net margin, TTM PG
FY Jun 2026
+18.4%
FY Jun 2025
+19.0%
FY Jun 2024
+17.7%
FY Jun 2023
+17.9%
FY Jun 2022
+18.4%
Sep 2026
+20.3%
Jun 2026
+14.4%
Mar 2026
+18.5%
Dec 2025
+19.4%
Sep 2025
+21.2%
Jun 2025
+17.3%
Mar 2025
+19.1%
Dec 2024
+21.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$15.3B
operating cash flow minus capex, 2025-10-01 to 2026-09-30
Free cash flow, TTM PG
FY Jun 2026
$15.1B
FY Jun 2025
$14.0B
FY Jun 2024
$16.5B
FY Jun 2023
$13.8B
FY Jun 2022
$13.6B
Sep 2026
$4.4B
Jun 2026
$4.1B
Mar 2026
$3.0B
Dec 2025
$3.8B
Sep 2025
$4.2B
Jun 2025
$4.0B
Mar 2025
$2.8B
Dec 2024
$3.9B
At each fiscal year end
Single quarter
Debt to equity
0.70x
long-term 2026-09-30 plus current 2026-09-30; equity 2026-09-30
Debt to equity PG
FY Jun 2026
0.63x
FY Jun 2025
0.66x
FY Jun 2024
0.64x
FY Jun 2023
0.74x
FY Jun 2022
0.67x
Sep 2026
0.70x
Jun 2026
0.63x
Mar 2026
0.68x
Dec 2025
0.69x
Sep 2025
0.67x
Jun 2025
0.66x
Mar 2025
0.65x
Dec 2024
0.67x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.51x
TTM operating cash flow over long-term 2026-09-30 plus current 2026-09-30
Cash flow to debt PG
FY Jun 2026
0.57x
FY Jun 2025
0.52x
FY Jun 2024
0.61x
FY Jun 2023
0.49x
FY Jun 2022
0.53x
Sep 2026
0.51x
Jun 2026
0.57x
Mar 2026
0.52x
Dec 2025
0.52x
Sep 2025
0.53x
Jun 2025
0.52x
Mar 2025
0.54x
Dec 2024
0.55x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+29.4%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on equity PG
FY Jun 2026
+30.1%
FY Jun 2025
+31.1%
FY Jun 2024
+30.5%
FY Jun 2023
+31.2%
FY Jun 2022
+31.5%
Sep 2026
+29.4%
Jun 2026
+30.1%
Mar 2026
+31.0%
Dec 2025
+31.4%
Sep 2025
+31.7%
Jun 2025
+31.1%
Mar 2025
+30.1%
Dec 2024
+30.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+12.3%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on assets PG
FY Jun 2026
+12.7%
FY Jun 2025
+12.9%
FY Jun 2024
+12.2%
FY Jun 2023
+12.3%
FY Jun 2022
+12.5%
Sep 2026
+12.3%
Jun 2026
+12.7%
Mar 2026
+13.2%
Dec 2025
+13.2%
Sep 2025
+13.2%
Jun 2025
+12.9%
Mar 2025
+12.8%
Dec 2024
+12.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital PG
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+22.3%
operating income (EBIT proxy) over average of 2025-09-30 and 2026-09-30 minus current liabilities
Return on capital employed PG
FY Jun 2026
+22.3%
FY Jun 2025
+23.0%
FY Jun 2024
+21.3%
FY Jun 2023
+21.4%
FY Jun 2022
+20.9%
Sep 2026
+22.3%
Jun 2026
+22.3%
Mar 2026
+22.5%
Dec 2025
+22.4%
Sep 2025
+22.8%
Jun 2025
+23.0%
Mar 2025
+22.7%
Dec 2024
+22.9%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
24.25x
close 2026-10-23 over four quarters of diluted EPS, 2025-10-01 to 2026-09-30
P/E, trailing PG
FY Jun 2026
22.15x
FY Jun 2025
24.47x
FY Jun 2024
27.40x
FY Jun 2023
25.72x
FY Jun 2022
24.71x
Sep 2026
21.88x
Jun 2026
22.15x
Mar 2026
21.12x
Dec 2025
21.23x
Sep 2025
22.43x
Jun 2025
24.47x
Mar 2025
27.05x
Dec 2024
26.70x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$402.8B
market value at close 2026-10-23 on 2026-09-30 shares, plus long-term 2026-09-30 plus current 2026-09-30, minus cash 2019-09-30
Enterprise value PG
FY Jun 2026
$366.3B
FY Jun 2025
$398.7B
FY Jun 2024
$412.4B
FY Jun 2023
$382.9B
FY Jun 2022
$367.2B
Sep 2026
$366.3B
Jun 2026
$366.3B
Mar 2026
$364.1B
Dec 2025
$360.4B
Sep 2025
$385.7B
Jun 2025
$398.7B
Mar 2025
$424.4B
Dec 2024
$418.5B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.1%
TTM free cash flow over market value at close 2026-10-23
FCF yield PG
FY Jun 2026
+4.4%
FY Jun 2025
+3.8%
FY Jun 2024
+4.2%
FY Jun 2023
+3.9%
FY Jun 2022
+3.9%
Sep 2026
+4.6%
Jun 2026
+4.4%
Mar 2026
+4.5%
Dec 2025
+4.5%
Sep 2025
+4.2%
Jun 2025
+3.8%
Mar 2025
+3.8%
Dec 2024
+3.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -3%, PEG needs growth
PEG, trailing PG
FY Jun 2026
13.11x
FY Jun 2025
3.01x
FY Jun 2024
13.47x
FY Jun 2023
18.71x
FY Jun 2022
4.11x
Sep 2026
n/a
Jun 2026
13.11x
Mar 2026
2.46x
Dec 2025
2.84x
Sep 2025
1.24x
Jun 2025
3.01x
Mar 2025
9.20x
Dec 2024
5.14x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PG ranks highest on profitability (88th percentile) and institutional and government (59th), and lowest on insider conviction (7th), among Consumer Goods peers.
Profitability
88
Inputs
Return on equity+29.4% · 89 pct, sector of 105
Return on assets+12.3% · 85 pct, sector of 124
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employed+22.3% · 89 pct, sector of 108
Financial health
47
Inputs
Debt to equity0.70x · 30 pct, sector of 112
Cash flow to debt0.51x · 64 pct, sector of 96
Growth
55
Inputs
Revenue growth, YoY+3.3% · 55 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
7
Inputs
Net Form 4 buying (codes P and S), 180d-$15.0M · 14 pct, sector of 80
Insider buyers, 180d0 · 0 pct, sector of 80
Institutional and government
59
Inputs
Funds adding, latest quarter1,867 · 100 pct, sector of 123
Congress net buyers, 365d-1 · 11 pct, universe of 719
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$820K · 67 pct, universe of 1,063
Risk and compliance
40
Inputs
Short interest, % of float+1.1% · 72 pct, sector of 157
Recalls per $1B revenue, 3y0.24 per $1B · 34 pct, universe of 292
EPA cases per $1B revenue, 5y0.01 per $1B · 11 pct, sector of 102
New text in Risk Factors, latest 10-K+14.8% · 45 pct, sector of 111
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PG filings, in plain words
Are Procter & Gamble insiders buying or selling PG?
In the 180 days to 2026-10-27, Procter & Gamble insiders were net sellers, a net $15.0M across purchases and sales reported on Form 4, by 12 sellers.
Have members of Congress traded PG?
Yes. In the year to 2026-10-27, 6 House members disclosed buying PG and 7 House members disclosed selling it; the latest on record is a sale by David J. Taylor dated 2026-10-12.
Are there planned insider sales of PG?
Yes. 25 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $29.2M of stock; the latest, by Santos de Azevedo Juliana Monteiro, was filed 2026-10-26.
Read the full summary
In the 180 days to 2026-10-27, Procter & Gamble insiders were net sellers of PG, a net $15.0M across purchases and sales reported on Form 4 by 12 sellers. None of the 21 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 6 members of Congress disclosed buying PG and 7 members disclosed selling it; the latest on record is a sale by David J. Taylor dated 2026-10-12. Insiders filed 25 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $29.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.